Mail icon

Mitigating the risk: manufacturing high potency drugs

27 March, 2018 | ChargePoint Technology

As the demand for high potency drug handling continues to rise, as does the need for high containment facilities.

However, currently many manufacturing facilities are unable to manage the upsurge and are needing to upgrade, develop and sometimes even construct new facilities to handle the significant demand. Under these circumstances it is more important than ever for companies to select the right partners with specialist containment solutions so they can adapt to the industry changes and containment challenges ahead.

Our very own Michael Avraam discusses the risks, challenges and innovative steps now being taken in today’s high potency sector with CPhI Online. You can read the full Q&A here. (